You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)預計上半年淨利同比增長53%-55%
格隆匯 07-15 18:42

格隆匯7月15日丨藥明康德(02359.HK)公佈,經公司財務部門初步測算,預計2021年上半年歸屬於公司股東的淨利潤與2020年上半年的人民幣17.17億元相比,增加人民幣9.10億元到人民幣9.44億元,同比增長53%到55%。

預計2021年上半年歸屬於公司股東的扣除非經常性損益的淨利潤與2020年上半年的人民幣11.31億元相比,增加人民幣9.73億元到人民幣9.95億元,同比增長86%到88%。

該期業績預增的主要原因:

(1)主營業務影響

公司預計歸屬於公司股東的淨利潤及歸屬於公司股東的扣除非經常性損益的淨利潤的增長率均將超過50%,是受以下兩項因素所推動:

1.從收入來看,憑藉2021年第一季度的強勁增長勢頭,加上合同研發與生產(CDMO)等業務的良好發展,本公司2021年第二季度收入繼續強勁增長。可比期間由於國內新冠疫情導致的成本影響已基本去除,故臨牀研究及其他合同研究服務(CRO)較去年同期實現了高增長。

2.從營業利潤來看,公司已自去年同期新冠疫情期間的低生產力期全面恢復。生產力及經營效率持續提升,營業利潤大幅增長。

(2)非經常性損益的影響

公司2021年上半年非經常性損益項目的影響與上年同期相比有所增長,主要由於公司所投資的已上市公司標的及非上市公司股權的市場價值上漲等原因,使公司部分非流動金融資產的公允價值變動收益以及投資收益增長較大,預計影響2021年上半年利潤金額人民幣20.49億元左右,上年同期影響金額為淨收益人民幣10.31億元。另一方面,由於公司H股可轉股債券衍生金融工具部分的公允價值受公司H股股價大幅上漲影響,2021年上半年非現金賬面公允價值損失金額預計為人民幣14.93億元左右,上年同期為淨損失人民幣4.87億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account